Introduction
============

Tongue squamous cell carcinoma (TSCC) has a particularly high mortality rate among malignancies, predominantly due to the difficulty of early detection, and its incidence is increasing rapidly according to the American Cancer Society ([@b1-mmr-16-06-9323],[@b2-mmr-16-06-9323]). Studies have shown that TSCC has a poorer prognosis and higher recurrence rate, compared with several other types of cancer due to metastasis being common ([@b3-mmr-16-06-9323]). Clinical results suggest that a lack of available biomarkers result in the majority of patients with TSCC not being diagnosed until an advanced stage. Therefore, understanding the molecular basis of tongue carcinogenesis may provide potential molecular markers for more rapid diagnosis of TSCC. Several biological molecules have been reported in the saliva and serum, and histological analysis has indicated that they are useful for screening and early detection of several types of cancer ([@b4-mmr-16-06-9323]--[@b6-mmr-16-06-9323]).

Serum is important for supporting cell viability and pH maintenance ([@b7-mmr-16-06-9323]), whereas saliva is important in oral hygiene, food digestion and the repair of mucosal damage, as demonstrated by animal behavioural experiments and *in vivo* analysis of patients ([@b8-mmr-16-06-9323]). Studies have suggested that saliva and serum are functionally similar and reflect the physiological state of the body ([@b9-mmr-16-06-9323]--[@b11-mmr-16-06-9323]), and that saliva is a non-invasive sample for potential clinical diagnosis. In the present study, serum deprivation experiments were performed on the Tca-8113 TSCC cell line to screen for potential biomarkers suitable for TSCC diagnosis. This was based on previous observations that serum deprivation synchronises proliferating cells at the G0 phase, induces apoptosis and stimulates the fibrotic response ([@b12-mmr-16-06-9323]).

The results of the present study showed that the Tca-8113 cells resisted serum deprivation-induced apoptosis. Two-dimensional gel electrophoresis (2-DE) and mass spectrometry-based protein identification were used for the proteomic analysis of serum-deprived Tca-8113 cells. The results provided insight for potential diagnostic biomarkers or drug targets for the treatment of TSCC.

Materials and methods
=====================

### Cell culture and MTT assay

The cells were routinely cultured, and MTT (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) assays were performed as previously described ([@b13-mmr-16-06-9323]). Briefly, the TSCC Tca-811 cell line, provided by the Ninth People\'s Hospital of Shanghai (Shanghai, China) was maintained by routine culturing in RPMI-1640 medium with 10% fetal bovine serum (FBS) (both from Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) in a 37°C incubator with 5% CO~2~. The cells were digested with 0.25% trypsin and seeded into 96-well plates (cat no. 3524; Corning Incorporated, Corning, NY, USA) at a density of 1×10^4^ cells/well and cultured for 18--24 h to 90% confluence. Serum deprivation was performed following washing twice with PBS. The cells were cultured for 12, 24, 36, 48 and 72 h following serum deprivation in the media at 37°C, with 10% serum as a control. Following cell culture, the culture medium were discarded, 200 µl of 0.5 mg/ml MTT in PBS was added to wells, and the cells were cultured for 4 h at 37°C. Following removal of the supernatants, 200 µl of DMSO was added and cells were shaken lightly for 15 min. The optical density value was measured using a microplate spectrophotometer (POWERWAVE 340; BioTek Instruments, Inc., Winooski, VT, USA) at 490 nm. All experiments were repeated four times and the mean ± standard deviation of results were calculated.

### Proteomic analysis

The proteomic experiments were performed as described previously ([@b14-mmr-16-06-9323]). The steps were as follows: i) At least 1.0×10^8^ Tca-8113 cells were harvested and lysed for sample preparation, and the bicinchoninic acid method was used for measurement of protein concentration; ii) each 80 µg sample was subjected to 2-DE on an Ettan IPGphor II apparatus (GE Healthcare Life Sciences, Chalfont, UK) in triplicate. Silver-stained gels were scanned at 300 dpi resolution, and differential analysis was performed to assign spots. Student\'s t-test was used for filtering, and spots with a fold-change \>1.2 were considered differentially expressed; iii) selected spots were subjected to MALDI-TOF mass spectrometry and tandem TOF/TOF mass spectrometry. The identified peptides were used for Basic Local Alignment Search Tool searches of the International Protein Index rat sequence database (<http://www.matrixscience.com>). The protein number, protein name, sequence coverage, score and Mr/pI were obtained and included in the analysis.

### Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis

The serum-deprivation treated Tca-8113 cells were prepared for one-step RT-qPCR SYBR Green assay as previous described ([@b15-mmr-16-06-9323]). Briefly, RNA was extracted using the TRIzol LS reagent and the cDNA Synthesis kit (both from Gibco; Thermo Fisher Scientific, Inc.) was used for cDNA synthesis. A total of 1 µl reverse transcriptase product was used to amplify the six genes (Annexin A1, peroxiredoxin 6, heat shock protein 27, heat shock protein 70, caspase-7 and GAPDH). Primers ([Table I](#tI-mmr-16-06-9323){ref-type="table"}) were designed based on the sequences of the five differentially expressed proteins identified in the proteomic analysis and GAPDH gene was used as reference. The primers were synthesized by Sangon Biotech (Shanghai) Co., Ltd. (Shanghai, China). The SYBR Green Real-Time PCR Master Mix (TOYOBO; Toyobo Life Science, Inc., Osaka, Japan) was used and the PCR cycling parameters were as follows: 94°C for 30 sec, followed by 35 cycles of 60°C for 30 sec and 72°C for 30 sec. A MyCycler thermal cycler (Bio-Rad Laboratories, Inc., Hercules, CA, USA) was used for the PCR analysis. Each gene was quantified by 2^−ΔΔCq^ method ([@b16-mmr-16-06-9323]) and the relative expression level was calculated by the ratio of each targeted gene to GAPDH gene.

### Statistical analysis

Data are reported as the mean ± standard deviation, and Student\'s t-tests were performed using the SPSS 16.0 software package (SPSS, Inc., Chicago, IL, USA). P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Serum deprivation inhibits cell proliferation

Serum deprivation inhibited the proliferation of cells, as exhibited in [Fig. 1](#f1-mmr-16-06-9323){ref-type="fig"}. When the Tca-8113 cells were subjected to serum deprivation for 12, 24, 36, 48 or 72 h, the proliferative activity was measured using an MTT assay. No significant differences were observed over time in the serum-deprived group (P\>0.05), however, proliferation continued to increase in the cells cultured in 10% FBS medium (P\<0.05).

### Identification of differentially expressed proteins using proteomic analysis

As proliferation was inhibited in the Tca-8113 cells subjected to serum deprivation for 24 h, the time-points of 0 h (control) and 24 h were selected for the comparison of triplicate samples using 2-DE and mass spectrometry. Representative 2-DE images are shown in [Fig. 2](#f2-mmr-16-06-9323){ref-type="fig"}. A total of 1,237 protein spots were detected on the 2-DE gel, with 43 significantly upregulated and 45 significantly downregulated at 24 h, compared with levels at 0 h (P\<0.05; average spot intensity difference \>1.2-fold). Of these 88 potential differentially expressed proteins, 35 were identified using MALDI-TOF/MS, whereas the remaining 53 did not yield suitably complete polypeptide fragments or were too low in abundance for reliable identification. The results of the spot ID, average spot intensity, protein number, protein name, sequence coverage, score and Mr/pI are exhibited in [Table II](#tII-mmr-16-06-9323){ref-type="table"}. The present study focussed on five differentially expressed proteins: Caspase-7 (spot 70), heat shock protein 27 (HSP 27; spot 390), Annexin A1 (spot 560), peroxiredoxin-6 (spot 405) and HSP 70 (spot 1194; [Fig. 3](#f3-mmr-16-06-9323){ref-type="fig"}). Notably, all are involved in mitochondrial oxidative stress, consistent with a previous conclusion that serum deprivation can induce apoptosis ([@b7-mmr-16-06-9323]).

### RT-PCR verification

The present study performed RT-PCR analysis to investigate the expression of caspase-7, HSP 27, Annexin A1, peroxiredoxin-6 and HSP 70 in the Tca-8113 cells subjected to serum deprivation at two time-points (0 and 16 h). The stably expressed GAPDH mRNA was selected as an internal reference gene as the expression of cytoskeletal proteins was significantly disrupted. For example, the expression of β-actin was increased at the protein ([Table II](#tII-mmr-16-06-9323){ref-type="table"}) and mRNA levels (data not shown), whereas the expression of tubulin was decreased ([Table II](#tII-mmr-16-06-9323){ref-type="table"}). As shown in [Fig. 4](#f4-mmr-16-06-9323){ref-type="fig"}, the expression patterns of the five proteins were similar to the results obtained using 2-DE.

Discussion
==========

Serum deprivation is widely used for cell cycle arrest and apoptosis, and various molecular mechanisms may be involved in the modulation of serum deprivation-induced apoptosis ([@b17-mmr-16-06-9323]). However, in the present study, the effects of serum deprivation on cell proliferation and apoptosis were not observed in the Tca-8113 cells, even following a long duration (72 h) of treatment ([Fig. 1](#f1-mmr-16-06-9323){ref-type="fig"}). The proteomic analysis showed that a 24 h period of serum deprivation induced significant expression changes of numerous mitochondrial proteins, including prohibitin, peroxiredoxin, glyoxalase, caspase and ATP synthase ([Table II](#tII-mmr-16-06-9323){ref-type="table"}). This is consistent with a previous study, in which mitochondrial function was readily disrupted by alterations of the cultivation environment through serum deprivation, which affects mitochondrial viability in several fibroblast lines ([@b18-mmr-16-06-9323]). However, the detailed molecular mechanism linking culture conditions and mitochondrial activity remains to be fully elucidated. The results of the present study provided novel insight into the mechanism by which Tca-8113 cells subjected to serum deprivation avoid apoptosis.

Although the mechanism by which serum deprivation stimulates reactive oxygen species (ROS) production remains to be elucidated, studies have shown that ROS resulting from serum deprivation can induce programmed cell death ([@b7-mmr-16-06-9323],[@b19-mmr-16-06-9323]). Oxidative stress has a wide range of effects on cellular proliferation, differentiation, migration and other physiological processes ([@b20-mmr-16-06-9323]). Several antioxidant proteins are involved in alleviating oxidative stress by removing ROS. The present study found that peroxiredoxin-2 (Prx2) was upregulated, whereas the associated Prx6 was downregulated following serum deprivation. Prx enzymes have six isoforms, and they are located at sites of energy production and cellular motion, where ROS can be produced in abundance, particularly in mitochondria and at the plasma membrane. The peroxiredoxins are known for their function in removing endogenous peroxides. Therefore, the upregulation of peroxiredoxins is linked to high levels of oxidative stress ([@b21-mmr-16-06-9323]). Prx2 is the major Prx enzyme in the cytoplasm, where it reduces peroxynitrite and hydroperoxides via a rapid, diffusion-controlled reaction ([@b22-mmr-16-06-9323]). Prx2 is also important in the mechanism of H~2~O~2~-induced redox signalling ([@b23-mmr-16-06-9323]). The overexpression of Prx2 has been associated with the progression of squamous cell carcinoma, and it may be an underlying biomarker for radiotherapy in colorectal cancer ([@b24-mmr-16-06-9323]) lung cancer ([@b25-mmr-16-06-9323]) and bladder cancer ([@b26-mmr-16-06-9323]). Similarly, the expression of Prx6 has been associated with high rates of metastasis of breast cancer cell lines, and the overexpression of Prx6 occurs in malignant mesothelioma, breast cancer, oesophageal carcinoma and oligodendroglioma ([@b27-mmr-16-06-9323]). A previous study revealed a marked upregulation of Prx2 following demethylation in gefitinib-resistant A549 cells ([@b28-mmr-16-06-9323]). The present results suggested that Tca-8113 cells may resist the serum deprivation-induced apoptosis by upregulating Prx2, which may serve as a potent target for assisting in anti-angiogenic drug treatment in human TSCC.

Annexin A1 (ANXA1) is a well-characterised apoptosis-associated membrane protein, which is regulated by the epidermal growth factor receptor, insulin receptor, TRPM7 channel kinase 1, protein kinase C and protein kinase A. ANXA1 has also been linked with carcinogenesis and metastasis in various types of tumour ([@b29-mmr-16-06-9323]). As an essential protein in tumourigenesis and apoptosis, the overexpression of ANXA1 is linked to carcinogenesis and high pathological differentiation grade ([@b30-mmr-16-06-9323],[@b31-mmr-16-06-9323]). There is accumulating evidence suggesting that ANXA1 may be regulated by pro-inflammatory proteins, including lipopolysaccharide and interleukin-6, and it is reported to act as a brake to control the inflammatory response ([@b32-mmr-16-06-9323]). Kang *et al* found that ANXA1 was positively upregulated during serum deprivation-induced autophagic degradation in HCT116 cells, indicating a potential role in autophagy by downregulating the inflammatory response ([@b33-mmr-16-06-9323]). The overexpression of ANXA1 can also inhibit the aberrant dysregulation of cytoskeletal proteins and proliferation of pulmonary microvascular endothelial cells ([@b34-mmr-16-06-9323]), which is consistent with the observed morphology, static proliferation and upregulation of actin in the serum deprived Tca-8113 cells in the present study. The results of the present study showed that ANXA1 was upregulated at the mRNA and protein levels following serum deprivation, suggesting that autophagy, and not apoptosis, was a factor in Tca-8113 cells; autophagy protected the cells against serum deprivation by promoting cell survival.

Autophagy and apoptosis are the two major cell death pathways, and are tightly regulated at the genetic level to ensure that tissue and organ development proceeds correctly, in addition to other pathophysiological processes ([@b35-mmr-16-06-9323]). A hallmark of autophagy is lysosomal degradation, which performs an adaptive function to protect organisms against infections, cancer and ageing ([@b36-mmr-16-06-9323]). Apoptosis is a programmed process for killing and removing certain cells during morphological development, which also assists in maintaining tissue homeostasis in multicellular organisms. The aberrant regulation of apoptosis has been consistently linked with human proliferative diseases, including malignant tumours ([@b37-mmr-16-06-9323]). Apoptosis involves a large number of molecules, including cysteine proteases in the form of caspases, which are synthesised as pro-forms and become activated by cleavage at aspartate residues. Initiator caspases, including caspase-1, 2, 4, 5, 8, 9, 10, 11 and 12, integrate molecular signals and activate downstream effector caspases, including caspase-3, 6, 7 and 14. As caspases can cleave and activate each other, triggering of the caspase cascade initiates a rapidly amplified signal, which ensures accurate apoptotic cell death. Caspases are also able to cleave several other substrates, including nuclear lamins and cytoskeletal proteins, thereby inducing typical morphological characteristics associated with apoptosis. Caspase-7 is most closely linked with caspase-3, and these enzymes are activated by mitochondria-induced apoptosis.

Effector caspases are in charge of initiating DNA fragmentation, cell shrinkage and membrane blebbing ([@b38-mmr-16-06-9323]). Brentnall *et al* ([@b39-mmr-16-06-9323]) showed that caspase-9 and caspase-3 are involved in remodeling of mitochondria and ROS production. Caspase-7 has no significant effect on sensitivity to intrinsic cell death, but is involved in ROS production and cell detachment. In the present study, serum deprivation upregulated the level of caspase-7 in Tca-8113 cells, which underwent shrinkage and membrane blebbing, suggesting that serum deprivation stimulated TSCC differentiation and inhibited cancer growth.

HSPs are also closely linked with stress responses, including the response to serum deprivation. HSP70 is a major stress-inducible protein, which can fulfil multiple roles depending on its location. The upregulation of intracellular HSP70 is involved in the stress associated with recovery from clinical treatment, including radiotherapy or chemotherapy, whereas extracellular HSP70 stimulates the innate immune system to initiate antitumour immunity ([@b40-mmr-16-06-9323]). In the present study, the serum deprivation-induced downregulation of HSP70 may assist TSCCs to escape and evade attacks from natural killer (NK) cells, however, the downregulation of major histocompatibility complex-I can compensate for this and ensure activation of the NK cells. HSP27 is primarily involved in proteasome-mediated protein degradation and the regulation of apoptosis. A previous study revealed that HSP27 mediates apoptotic programming in pancreatic cancer cells ([@b41-mmr-16-06-9323]), and clinical immunohistochemical evidence demonstrates that the overexpression of HSP27 causes high-grade differentiation in TSCCs ([@b42-mmr-16-06-9323]). Therefore, the serum deprivation-induced upregulation of HSP27 may be correlated with the morphology and differentiation of TSCCs, consistent with the expression of caspase-7.

In conclusion, the present investigative preclinical study found that Tca-8113 TSCC cells resisted apoptosis induced by serum deprivation. The changes in proteins were primarily involved in the oxidative stress process in the mitochondrion, which indicated that ROS may be important in serum deprivation-induced oxidative stress. In the future, further detailed investigations on the signalling pathway and clinical verification are required.
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![Proliferative activity of Tca-8113 cells subjected to serum deprivation. Experiments were repeated four times. \*P\<0.05.](MMR-16-06-9323-g00){#f1-mmr-16-06-9323}

![Typical silver-stained 2-DE polyacrylamide gel. Numbers refer to differentially expressed protein spots in Tca-8113 cells subjected to serum deprivation for (A) 0 h and (B) and 24 h.](MMR-16-06-9323-g01){#f2-mmr-16-06-9323}

![Mean relative abundance of five selected differentially expressed proteins (data extracted from [Table II](#tII-mmr-16-06-9323){ref-type="table"} and [Fig. 2](#f2-mmr-16-06-9323){ref-type="fig"}).](MMR-16-06-9323-g02){#f3-mmr-16-06-9323}

![Verification of five selected differentially expressed proteins by reverse transcription-polymerase chain reaction analysis of mRNA levels following 16 h serum-deprivation. The relative expression levels of the mRNA were measured with GAPDH as reference. Experiments were repeated three times with similar results. \*P\<0.05 vs. 0 h.](MMR-16-06-9323-g03){#f4-mmr-16-06-9323}

###### 

Reverse transcription-polymerase chain reaction primer sequences for the six genes.

  Gene                    Primer sequence                    Length (bp)
  ----------------------- ---------------------------------- -------------
  Annexin A1              F: 5′-AAGACTTGGCTGATTCAGATGC-3′    124
                          R: 5′-AACACTCTGCGAAGTTGTGGATA-3′   
  Peroxiredoxin 6         F: 5′-CGCATCCGTTTCCACGACTT-3′      271
                          R: 5′-TGGCAAGCTCCCGATTCCTAT-3′     
  Heat shock protein 27   F: 5′-AGTGGTCGCAGTGGTTAGGC-3′      186
                          R: 5′-GGTTGACATCCAGGGACACG-3′      
  Heat shock protein 70   F: 5′-CTGCTGCGACAGTCCACTACC-3′     177
                          R: 5′-TCGGCTCCGCTCTGAGATT-3′       
  Caspase-7               F: 5′-GAAGAGGCTCCTGGTTTGTG-3′      106
                          R: 5′-CTGGCAACTCTGTCATTCACC-3′     
  GAPDH                   F: 5′-GGGAAACTGTGGCGTGAT-3′        299
                          R: 5′-GAGTGGGTGTCGCTGTTGA-3′       

GAPDH, glyceraldehyde phosphate dehydrogenase; F, forward; R, reverse.

###### 

List of differentially expressed proteins during serum-deprivation treatment.

                  Percentage of total volume of all spots^[a](#tfn2-mmr-16-06-9323){ref-type="table-fn"}^                                                                                                                                       
  --------------- ----------------------------------------------------------------------------------------- ------------- --------------- ----------------------------------------------------------------------------------------- ---- ------ --------------
  Upregulated                                                                                                                                                                                                                                   
    59            0.000±0.000                                                                               0.086±0.005   gi\|2250700     KNP-I α protein                                                                           62   138    23,806/8.61
    489           0.000±0.000                                                                               0.002±0.001   gi\|4505773     Prohibitin                                                                                58   197    29,843/5.57
    497           0.000±0.000                                                                               0.153±0.005   gi\|28931       β-subunit (AA 1--312)                                                                     42     95   34,026/4.90
    566           0.001±0.001                                                                               0.110±0.015   gi\|194376310   Actin, β, partial                                                                         34   174    38,950/5.19
    343           0.007±0.004                                                                               0.214±0.030   gi\|194375974   Peroxiredoxin-2                                                                           57   193    20,209/8.90
    70            0.016±0.010                                                                               0.156±0.016   gi\|20150093    Chain B, crystal structure of caspase-7 complexed with xiap                               63   143    12,244/5.73
    220           0.010±0.003                                                                               0.090±0.004   gi\|55959240    Nicotinamide nucleotide adenylyltransferase 1                                             66   132    18,413/8.99
    103           0.078±0.023                                                                               0.417±0.035   gi\|1362965     T cell receptor Mb11 β chain                                                              48   109    15,697/6.56
    376           0.076±0.024                                                                               0.399±0.017   gi\|5822016     Chain C, erythropoietin complexed with extracellular domains of erythropoietin receptor   66   165    18,655/9.28
    549           0.065±0.019                                                                               0.250±0.024   gi\|21667979    Oxysterol binding protein-related protein 3 isoform 2d                                    40   123    35,786/5.11
    390           0.456±0.037                                                                               1.119±0.024   gi\|662841      Heat shock protein 27                                                                     39   111    22,427/7.83
    560           0.439±0.035                                                                               1.011±0.071   gi\|4502101     Annexin A1                                                                                52   215    38,918/6.57
    392           0.856±0.067                                                                               1.734±0.087   gi\|1871210     T-complex protein 1, β subunit (TCP-1-β)                                                  63   154    22,924/5.88
  Downregulated                                                                                                                                                                                                                                 
    358           1.744±0.043                                                                               1.021±0.067   gi\|2392338     Glyoxalase-I                                                                              42   121    20,861/5.12
    775           0.852±0.030                                                                               0.456±0.067   gi\|301030821   c-Myc promoter-binding protein 1                                                          42   100    36,874/6.17
    1184          0.416±0.007                                                                               0.174±0.012   gi\|194388088   Heat shock 70 kDa protein 1A/1B                                                           34   205    64,170/5.39
    1162          0.120±0.004                                                                               0.050±0.011   gi\|194384236   Heat shock 70 kDa protein 1A/1B                                                           19     87   60,091/5.39
    1194          0.774±0.028                                                                               0.311±0.029   gi\|62897129    Heat shock 70 kDa protein 8 isoform 1 variant                                             17     78   71,083/5.28
    885           1.450±0.087                                                                               0.476±0.039   gi\|92911770    XTP3TPA-transactivated protein 1                                                          50   146    23,896/6.42
    714           0.822±0.156                                                                               0.233±0.076   gi\|296211572   Tubulin α-1B chain isoform 2                                                              30   110    46,797/4.96
    204           0.327±0.035                                                                               0.057±0.018   gi\|56605994    CDGSH iron-sulfur domain-containing protein 2                                             82   177    15,497/9.66
    1077          0.055±0.005                                                                               0.005±0.003   gi\|32189394    ATP synthase subunit β, mitochondrial precursor                                           46   208    56,525/5.26
    198           0.161±0.022                                                                               0.000±0.000   gi\|57162210    CDC14 cell division cycle 14 homolog B (S. cerevisiae)                                    47   126    31,655/8.33
    206           0.107±0.012                                                                               0.000±0.000   gi\|51479152    ATP synthase subunit d, mitochondrial isoform b                                           48     89   15,820/6.60
    245           0.052±0.010                                                                               0.000±0.000   gi\|119595056   Glutathione S-transferase pi, isoform CRA_c                                               24     41   19,577/4.84
    314           0.054±0.009                                                                               0.000±0.000   gi\|306517833   MHC class I antigen                                                                       48   109    21,098/6.64
    405           0.356±0.006                                                                               0.000±0.000   gi\|4758638     Peroxiredoxin-6                                                                           41   133    25,133/6.00
    419           0.267±0.034                                                                               0.000±0.000   gi\|3329384     Translation initiation factor 4e                                                          55   131    27,481/10.00
    772           0.076±0.004                                                                               0.000±0.000   gi\|7705592     Mediator of RNA polymerase II transcription subunit 31                                    61   201    15,966/8.72
    845           0.131±0.003                                                                               0.000±0.000   gi\|89574029    Mitochondrial ATP synthase, H+ transporting F1 complex β subunit                          39   134    48,083/4.95
    1000          0.235±0.047                                                                               0.000±0.000   gi\|48146259    CCT2                                                                                      31   159    57,766/6.01
    1006          0.173±0.035                                                                               0.000±0.000   gi\|220702506   Chain A, TapasinERP57 HETERODIMER                                                         34   174    54,541/5.61
    1080          0.052±0.003                                                                               0.000±0.000   gi\|169404695   Chain A, pyruvate kinase M2, phosphotyrosine binding protein                              29   153    57,091/8.00
    1189          0.063±0.010                                                                               0.000±0.000   gi\|14718539    HIC-3                                                                                     15     82   65,103/5.89
    1222          0.186±0.005                                                                               0.000±0.000   gi\|386758      GRP78 precursor, partial                                                                  32   169    72,185/5.03
    1230          0.035±0.001                                                                               0.000±0.000   gi\|15293595    Seven transmembrane helix receptor                                                        43     85   24,812/8.87

Data are presented as the mean ± standard deviation. Mr/pI, molecular mass/isoelectric point.
